Vincent O'Neill, Chief Medical Officer at BioXcel Therapeutics, Inc. (BTAI), sold 50,000 shares at $50.77 ($2.6M) on 2020-12-28, disclosed to the SEC on 2020-12-30.
Open-market sale of $2.6M BTAI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.77 | 13,969 | $709K | 27.6% |
| 2 | $50.77 | 13,969 | $709K | 27.6% |
| 3 | $51.75 | 5,727 | $296K | 11.5% |
| 4 | $51.75 | 5,727 | $296K | 11.5% |
| 5 | $52.68 | 3,951 | $208K | 8.1% |
| 6 | $52.68 | 3,951 |
| $208K |
| 8.1% |
| 7 | $53.54 | 1,353 | $72K | 2.8% |
| 8 | $53.54 | 1,353 | $72K | 2.8% |
| Total | $51.45 avg | 50,000 | $2.6M | 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $95 | — | Filing → |
| BTAI | SELL | 2024-06-18 | $200 | — | Filing → |
| BTAI | SELL | 2024-04-08 | $432 | — | Filing → |